Site Members can sign up for company wide alerts
Lawsuit Overview
May 26, 2022 - An investor in shares of Spero Therapeutics, Inc. (NASDAQ: SPRO) filed a lawsuit in the U.S. District Court for the Eastern District of New York over alleged violations of Federal Securities Laws by Spero Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between October 28, 2021 and May 2, 2022. Cambridge, MA based Spero Therap...
You must register (for free) or login to view the entire case.